4.7 Article

Epigenetic and Transcriptional Networks Underlying Atrial Fibrillation

Journal

CIRCULATION RESEARCH
Volume 127, Issue 1, Pages 34-50

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCRESAHA.120.316574

Keywords

atrial fibrillation; myocytes; cardiac; genetic variation; genome-wide association study; transcription factors

Funding

  1. Fondation Leducq [14CVD01]
  2. American Heart Association [18SFRN34110082]
  3. National Institutes of Health [1RO1HL092577, R01HL128914, K24HL105780, 5K01HL140187, HL127717, HL130804, HL118761]
  4. NIH [F30HL131298, T32-HL007381, F31HL144023, T32HD055164]
  5. AHA Strategically Focused Research Networks (SFRN) postdoctoral fellowship [18SFRN34110082]
  6. NHLBI [F30HL145908]
  7. Baylor Research Advocates for Student Scientists (BRASS)
  8. Vivian L. Smith Foundation, State of Texas
  9. European Union [633196]
  10. European Union BigData@Heart [EU IMI 116074]
  11. British Heart Foundation [FS/13/43/30324, PG/17/30/32961, AA/18/2/34218]
  12. German Centre for Cardiovascular Research
  13. German Ministry of Education and Research (DZHK)
  14. AHA [17CSA33610126]
  15. [R01 HL147571]
  16. [R01 HL148719]
  17. [R01 HL126509]

Ask authors/readers for more resources

Genome-wide association studies have uncovered over a 100 genetic loci associated with atrial fibrillation (AF), the most common arrhythmia. Many of the top AF-associated loci harbor key cardiac transcription factors, including PITX2, TBX5, PRRX1, and ZFHX3. Moreover, the vast majority of the AF-associated variants lie within noncoding regions of the genome where causal variants affect gene expression by altering the activity of transcription factors and the epigenetic state of chromatin. In this review, we discuss a transcriptional regulatory network model for AF defined by effector genes in Genome-wide association studies loci. We describe the current state of the field regarding the identification and function of AF-relevant gene regulatory networks, including variant regulatory elements, dose-sensitive transcription factor functionality, target genes, and epigenetic states. We illustrate how altered transcriptional networks may impact cardiomyocyte function and ionic currents that impact AF risk. Last, we identify the need for improved tools to identify and functionally test transcriptional components to define the links between genetic variation, epigenetic gene regulation, and atrial function.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available